UND researchers report association between radon exposure and ovarian cancer
GRAND FORKS, N.D. – A first-of-its-kind study published by University of North Dakota researchers today in JAMA Network Open reveals a significant association between residential radon gas—a common, modifiable environmental hazard—and an increased risk of ovarian cancer incidence and mortality among postmenopausal women.
The study, led by researchers at the UND School of Medicine & Health Sciences (SMHS) and the University of North Carolina at Chapel Hill, analyzed data from over 127,000 women participating in the Women’s Health Initiative (WHI) over a 31-year period. The findings show that women living in “high” radon zones, as defined by the U.S. Environmental Protection Agency (EPA), face a significantly higher risk of developing ovarian cancer compared to those in low-exposure areas.
A novel approach to ovarian cancer research
According to the Ovarian Cancer Research Alliance, ovarian cancer remains the fifth leading cause of cancer deaths among women in the United States. While genetic factors and reproductive history are well-known risk factors, environmental causes have remained elusive.
“We have known for decades that radon is a leading cause of lung cancer, but its impact on other organs has been a subject of intense debate,” said Mark R. Williamson, research assistant professor in the SMHS Department of Population Health, and lead author of the study. “This research provides the first individual-level evidence that the ionizing radiation from radon gas may be a target for mitigating ovarian cancer risk.”
The research team linked geocoded home addresses of 127,547 postmenopausal women to US Geological Survey (USGS) radon zones. Over an average follow-up of nearly 18 years, the study observed 1,645 ovarian cancer cases and 1,048 ovarian cancer deaths.
The study found that women in high radon zones (levels exceeding 4 picocuries per liter or pCi/L) had a significantly higher “hazard ratio” for ovarian cancer compared to those in low radon zones (less than 2 pCi/L). The association was particularly strong for serous ovarian cancer, the most lethal and common type, with a 38% increased risk in high radon areas. Even more, the risk of dying from ovarian cancer was also 31% higher for women residing in high radon zones.
Colorless, odorless
Radon is a naturally occurring radioactive gas produced by the decay of uranium in soil. It enters homes through foundation cracks and can accumulate to dangerous levels. While primarily inhaled, radon gas is soluble in blood and can reach internal organs.
For this reason, the study posits two biological mechanisms for the association between radon and ovarian cancer. First, as radon decays, its “progeny” may be carried to ovarian tissues via particulate air pollution, acting as a “Trojan horse” to deliver alpha-particle radiation directly to the cells. At the same time, previous research has indicated that radon inhalation can significantly increase levels of estradiol and other hormones in the blood, making radon a hormone “disruptor,” the consequences of which can include cancer.
Unlike many genetic risk factors for cancer, though, radon exposure can be mitigated through radon testing and removal. Unfortunately, noted Gary Schwartz, professor and chair of the SMHS Department of Population Health, only about 18% of U.S. homes have ever been tested for radon, despite approximately 25% of the population living in high-radon areas.
“Residential radon is a ubiquitous exposure, but it is one we can control,” said Schwartz, who was senior author on the study. “If these findings are replicated, radon testing and mitigation could become a vital component of ovarian cancer prevention strategies.”
Next steps
The researchers cautioned that while the study is robust, it focused exclusively on postmenopausal women. Additionally, because the radon data was based on regional estimates rather than individual home tests, the results may not reflect personal exposure levels for every participant.
Even so, Williamson and Schwartz said that the next step is more research, which is already underway at UND. The pair is also hard at work finalizing a radon test chamber at UND – one of only a few in the country – that will enable area researchers to test the effects of radon on cells directly.
“If we can change a common exposure and do things like make sure new homes have radon resistant construction and make sure women at high risk for ovarian cancer check their radon levels and change them,” Schwartz concluded, “we’d be saving lives.”
# # #
Brian James Schill
Director, Office of Alumni & Community Relations
UND School of Medicine & Health Sciences
701.777.6048 direct | 701.777.4305 office
brian.schill@UND.edu | med.UND.edu